Novartis Investigative Site

Chermside, Queensland 4032

0 studies enrolling now · 2 studies all time

What they study most

Idiopathic Pulmonary Fibrosis, Non Small Cell Lung Cancer

Studies at this site

• To Assess the Efficacy of the Investigational Products Compared to Placebo in Participants With IPF — Stopped early
• Study of Efficacy and Safety of Nivolumab in Combination With EGF816 and of Nivolumab in Combination With INC280 in Patients With Previously Treated Non-small Cell Lung Cancer — Stopped early